HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Natalia Davydova Selected Research

Vascular Endothelial Growth Factor D

12/2016Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
8/2013Vascular endothelial growth factor-d modulates caliber and function of initial lymphatics in the dermis.
3/2013The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology.
3/2012Preparation of human vascular endothelial growth factor-D for structural and preclinical therapeutic studies.
8/2011Proteolytic processing of vascular endothelial growth factor-D is essential for its capacity to promote the growth and spread of cancer.
4/2011The VD1 neutralizing antibody to vascular endothelial growth factor-D: binding epitope and relationship to receptor binding.
4/2007Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Natalia Davydova Research Topics

Disease

7Neoplasms (Cancer)
12/2016 - 12/2005
4Neoplasm Metastasis (Metastasis)
12/2016 - 12/2005
3Lymphatic Metastasis
08/2011 - 12/2005
2Lymphedema (Milroy Disease)
12/2016 - 03/2012
1Dementia (Dementias)
10/2013
1Alzheimer Disease (Alzheimer's Disease)
10/2013
1Wounds and Injuries (Trauma)
08/2013
1Cardiovascular Diseases (Cardiovascular Disease)
03/2012

Drug/Important Bio-Agent (IBA)

7Vascular Endothelial Growth Factor DIBA
12/2016 - 04/2007
5Proteins (Proteins, Gene)FDA Link
12/2016 - 12/2005
4EnzymesIBA
12/2016 - 12/2005
2Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
12/2016 - 08/2011
2Glycoproteins (Glycoprotein)IBA
12/2016 - 03/2012
1Messenger RNA (mRNA)IBA
12/2016
1Vascular Endothelial Growth Factor CIBA
12/2016
1ProstaglandinsIBA
12/2016
1Peptides (Polypeptides)IBA
10/2013
1Amyloid (Amyloid Fibrils)IBA
10/2013
1MetalsIBA
10/2013
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2013
1Heparin (Liquaemin)FDA LinkGeneric
03/2013
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
08/2011
1MitogensIBA
08/2011
1Matrix Metalloproteinases (MMPs)IBA
04/2007
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
12/2005
1Cell Surface ReceptorsIBA
12/2005

Therapy/Procedure

6Therapeutics
12/2016 - 12/2005